WO2025144118 - NOVEL POLYMORPH OF RIBOCICLIB DIHYDROCHLORIDE DIHYDRATE AND METHOD OF PREPARATION
National phase entry is expected:
Publication Number
WO/2025/144118
Publication Date
03.07.2025
International Application No.
PCT/TR2023/051733
International Filing Date
27.12.2023
Title **
[English]
NOVEL POLYMORPH OF RIBOCICLIB DIHYDROCHLORIDE DIHYDRATE AND METHOD OF PREPARATION
[French]
NOUVEAU POLYMORPHE DE DIHYDROCHLORURE DIHYDRATÉ DE RIBOCICLIB ET PROCÉDÉ DE PRÉPARATION
Applicants **
DEVA HOLDING
Inventors
HAAS, Philipp Daniel
STECKEL, Hartwig Andreas
BELLUR ATİCİ, Esen
IŞIKSEL, Ecem
ŞANLI, Cansu
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1986 | |
| EPO | Filing, Examination, Granting | 9400 | |
| Japan | Filing, Examination, Granting | 2056 | |
| South Korea | Filing, Examination, Granting | 1756 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
21,738
Contact Us
Abstract[English]
The present invention refers to a crystalline form of Ribociclib dihydrochloride (dihydrate) designated as Form A and a process for its preparation, a pharmaceutical composition comprising it, and its use for the the treatment of breast cancer.[French]
La présente invention concerne une forme cristalline de dihydrochlorure de ribociclib (dihydraté) désignée comme forme A et un procédé pour sa préparation, une composition pharmaceutique la comprenant, et son utilisation pour le traitement du cancer du sein.